Author:
Menger Jenna M.,Sathianathen Ryan S.,Sakamoto Kathleen M.,Hijiya Nobuko
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2023. [updated: 2023 Nov 16; cited 2024 Feb 9]. Available from: https://seer.cancer.gov/statistics-network/explorer/. Data source(s): SEER Incidence Data, November 2022 Submission (1975-2020), SEER 22 registries.
2. Athale U, et al. Management of chronic myeloid leukemia in children and adolescents: recommendations from the Children’s Oncology Group CML Working Group. Pediatr Blood Cancer. 2019;66(9):e27827.
3. Youn M, et al. Comparison of the transcriptomic signatures in pediatric and adult CML. Cancers (Basel). 2021;13(24):6263.
4. Haznedaroğlu İC, Kuzu I, İlhan O. WHO 2016 Definition of chronic myeloid leukemia and tyrosine kinase inhibitors. Turk J Haematol. 2020;37(1):42–7.
5. Vardiman JW. Chronic myelogenous leukemia, BCR-ABL1+. Am J Clin Pathol. 2009;132(2):250–60.